Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) had its price objective lowered by Piper Sandler from $10.00 to $6.00 in ...

Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

As the U.S. stock market faces a turbulent period with major indices like the Dow Jones and S&P 500 on track for their worst week in two years, concerns about tariffs and economic health continue to ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the stock. Several other brokerages have ...

In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate). BEDMINSTER, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings ...

which are available on the SEC’s website at www.sec.gov. Contacts AEON Biopharma NewsMORE Related Stocks ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...